We speculate that changes in the expression of SMS in pancreatic cancer could affect the levels of spermidine and spermine in cells, while changes in spermidine/spermine levels could affect the phosphorylation of AKT and ultimately affect the activation and inhibition of the AKT signaling pathway. This evidence concerns the gene AKT1 and pancreatic neoplasm.